Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP331900.RAQpc6AmaZUYwc8chyy_Z5vJJDtmdBAxU9dcRVDu1oJBI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP331900.RAQpc6AmaZUYwc8chyy_Z5vJJDtmdBAxU9dcRVDu1oJBI130_assertion type Assertion NP331900.RAQpc6AmaZUYwc8chyy_Z5vJJDtmdBAxU9dcRVDu1oJBI130_head.
- NP331900.RAQpc6AmaZUYwc8chyy_Z5vJJDtmdBAxU9dcRVDu1oJBI130_assertion description "[That observation was supported by the findings that p202-expressing tumors showed reduced expression of angiogenic markers, such as interleukin 8 and vascular endothelial growth factor, and p202-expressing pancreatic cancer cells have reduced level of matrix metalloproteinase-2 activity, a secreted protease activity important for metastasis.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP331900.RAQpc6AmaZUYwc8chyy_Z5vJJDtmdBAxU9dcRVDu1oJBI130_provenance.
- NP331900.RAQpc6AmaZUYwc8chyy_Z5vJJDtmdBAxU9dcRVDu1oJBI130_assertion evidence source_evidence_literature NP331900.RAQpc6AmaZUYwc8chyy_Z5vJJDtmdBAxU9dcRVDu1oJBI130_provenance.
- NP331900.RAQpc6AmaZUYwc8chyy_Z5vJJDtmdBAxU9dcRVDu1oJBI130_assertion SIO_000772 11585747 NP331900.RAQpc6AmaZUYwc8chyy_Z5vJJDtmdBAxU9dcRVDu1oJBI130_provenance.
- NP331900.RAQpc6AmaZUYwc8chyy_Z5vJJDtmdBAxU9dcRVDu1oJBI130_assertion wasDerivedFrom befree-2016 NP331900.RAQpc6AmaZUYwc8chyy_Z5vJJDtmdBAxU9dcRVDu1oJBI130_provenance.
- NP331900.RAQpc6AmaZUYwc8chyy_Z5vJJDtmdBAxU9dcRVDu1oJBI130_assertion wasGeneratedBy ECO_0000203 NP331900.RAQpc6AmaZUYwc8chyy_Z5vJJDtmdBAxU9dcRVDu1oJBI130_provenance.